Armata Pharmaceuticals Makes Progress in Phage Therapy with New Publication in Molecular Biology Armata Pharmaceuticals has shared groundbreaking research on phage Pa223, highlighting its potential in treating chronic bacterial infections. This study opens doors for innovative therapeutic solutions.

Armata Pharmaceuticals Makes Progress in Phage Therapy with New Publication in Molecular Biology #USA #Los_Angeles #phage_therapy #Armata_Pharmaceuticals #Pa223

Armata Pharmaceuticals Reports Q4 and Full-Year 2024 Financial Results and Updates on Clinical Progress Armata Pharmaceuticals shares its fourth quarter and full-year 2024 financial results, revealing significant clinical trial progress and a new funding agreement.

Armata Pharmaceuticals Reports Q4 and Full-Year 2024 Financial Results and Updates on Clinical Progress #USA #Los_Angeles #phage_therapy #Armata_Pharmaceuticals #AP-PA02

Diverse Phage Populations Uncovered in Gut Bacteria to Combat Infections A groundbreaking study reveals how phages interact within gut bacteria, paving the way for innovative treatments against antibiotic-resistant infections, showcasing their ecological roles.

Diverse Phage Populations Uncovered in Gut Bacteria to Combat Infections #United_States #New_York #E._coli #NYU_Grossman #phage_therapy